Xero Shares Pull Back from Resistance, Offers Relief in Green Week

Xero shares had three negative sessions to end last week, with a 1.41% dip on Friday seeing XRO close out at A$79.27. This wrapped up a volatile week for holders, that saw Xero’s share price deliver a 5.45% gain despite fierce resistance at the A$87 level and a sharp pullback from Tuesday’s high.

The A$87 price zone has now repelled rallies three times so far in 2026; first in March, again in May, and most recently this week, establishing itself as a formidable level of resistance for bulls attempting to mount a sustained recovery.

Despite the Friday fade, the 5.45% weekly advance offered a rare moment of respite for shareholders nursing substantial losses. Year-to-date, Xero’s share price remains down 29.38%, while the 12-month decline has reached a punishing 58%, reflecting a brutal de-rating that has stripped billions from the company’s market capitalisation since mid-2025.

The price action underscores a market caught between fundamental believers willing to accumulate on dips, and valuation-conscious sellers using any strength to reduce exposure.

Xero Fundamentals

The current sentiment split stems directly from Xero’s FY26 full-year results, released on 14 May 2026, which delivered a stark contrast between top-line momentum and bottom-line disappointment.

Revenue surged approximately 31% to reach US$2.75-2.8 billion, representing roughly 28% growth in constant currency terms. The performance was underpinned by continued subscriber growth, higher average revenue per user across core markets in Australia, New Zealand, and the United Kingdom, plus early contributions from the Melio acquisition completed in October 2025.

Adjusted EBITDA rose a more modest 18% to approximately US$750 million, signalling margin pressure as the company invests heavily in US expansion and Melio integration. The real shock came in statutory net profit after tax, which plunged 27% year-on-year, weighed down by roughly US$50 million in transaction costs related to the Melio deal, foreign exchange impacts, and elevated operating expenses tied to the company’s land-grab strategy in North America.

Management characterised FY26 as a “milestone year” during which Xero achieved consistent free cash flow positivity at multi-billion-dollar revenue scale, but acknowledged that near-term margin expansion would remain constrained by strategic investments. The Melio acquisition, valued at up to US$500 million including earn-outs, is designed to deepen Xero’s payments capabilities and boost customer lifetime value, though markets remain divided on whether the deal will prove accretive or dilutive over the medium term.

Xero shares fell 9.04% on results day, as markets focused squarely on the profit miss and higher-than-expected cost base.

The Setup

The technical picture mirrors the fundamental debate. The A$87 resistance level has now capped three separate rally attempts in 2026, suggesting supply remains heavy at that threshold.

Bears argue the stock is still overvalued relative to current profitability, particularly given execution risks in the US market and structural concerns around artificial intelligence platforms eroding software moats or compressing margins across the SaaS sector.

Yet the bullish counter-narrative remains potent. Xero has de-levered its balance sheet, is generating robust cash flow, and is posting elite revenue growth rates at significant scale. Bulls contend that once Melio scaling costs roll off and US expansion matures, margins could inflect sharply higher, rewarding patient investors who accumulate at current prices.

A positive week overall is a win for bulls, however, without a catalyst to break the A$87 ceiling, Xero shares may continue to trade in a wide range, with bulls finding periodic relief in green weeks but lacking the momentum to drive a sustained recovery. Value opportunity, or value trap? Time will tell.